Sally Suliman is a Respiratory physician. OpenAlex indexes 44 publications with 399 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
401 E Chestnut St Unit 370
Louisville, KY 40202
Telephone
502-588-4710Provider last certified this registry record 23 Jan 2020.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year202512 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- La Jolla Pharmaceutical CompanyProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
47.3%Corticosteroid31.2%Prednisone100%Part D≥19 patientsProton pump inhibitor16.1%Omeprazole58%Pantoprazole Sodium42%Part D<11 patientsCancer & immunology
30.8%Kinase inhibitor17%Ofev100%Part D<11 patientsPurine Antimetabolite7.1%Azathioprine100%Part D<11 patients+ 1 more class in this area
Respiratory
13.4%beta2-Adrenergic Agonist6.7%Albuterol Sulfate Hfa100%Part D<11 patientsCorticosteroid6.7%Trelegy Ellipta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of carbon nanotubes on pulmonary disorders attributed to occupational and environmental exposures
Nanomedicine Nanotechnology Biology and Medicine
2025 - Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Respiratory Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”